pTwist-SARS-CoV-2 Δ18 B.1.1.529 Citations (12)
Originally described in: mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB Cell. 2022 Jan 6. pii: S0092-8674(21)01496-3. doi: 10.1016/j.cell.2021.12.033. PubMed Journal
Articles Citing pTwist-SARS-CoV-2 Δ18 B.1.1.529
| Articles |
|---|
| SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses. Shah M, Ung Moon S, Hyun Kim J, Thanh Thao T, Goo Woo H. Comput Struct Biotechnol J. 2022;20:2042-2056. doi: 10.1016/j.csbj.2022.04.030. Epub 2022 Apr 26. PubMed |
| Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19. Khanna K, Raymond WW, Jin J, Charbit AR, Gitlin I, Tang M, Werts AD, Barrett EG, Cox JM, Birch SM, Martinelli R, Sperber HS, Franz S, Duff T, Hoffmann M, Healy AM, Oscarson S, Pohlmann S, Pillai SK, Simmons G, Fahy JV. Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L372-L389. doi: 10.1152/ajplung.00136.2022. Epub 2022 Jun 28. PubMed |
| PEDOT:PSS in Solution Form Exhibits Strong Potential in Inhibiting SARS-CoV-2 Infection of the Host Cells by Targeting Viruses and Also the Host Cells. Hung JN, Kha Vo DN, Thanh Ho HP, Tsai MH. Biomacromolecules. 2022 Sep 12;23(9):3535-3548. doi: 10.1021/acs.biomac.2c00271. Epub 2022 Aug 2. PubMed |
| Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion. Ho HPT, Vo DNK, Lin TY, Hung JN, Chiu YH, Tsai MH. Biomed Pharmacother. 2022 Nov;155:113766. doi: 10.1016/j.biopha.2022.113766. Epub 2022 Sep 28. PubMed |
| Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia. Fu JYL, Pukhari MH, Bador MK, Sam IC, Chan YF. Viruses. 2023 Mar 25;15(4):844. doi: 10.3390/v15040844. PubMed |
| The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Wu CY, Yang YH, Lin YS, Shu LH, Cheng YC, Liu HT, Lin YY, Lee IY, Shih WT, Yang PR, Tsai YY, Chang GH, Hsu CM, Yeh RA, Wu YH, Wu YH, Shen RC, Tsai MS. Heliyon. 2023 Jul 3;9(7):e17701. doi: 10.1016/j.heliyon.2023.e17701. eCollection 2023 Jul. PubMed |
| High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2. Chan CWF, Wang B, Nan L, Huang X, Mao T, Chu HY, Luo C, Chu H, Choi GCG, Shum HC, Wong ASL. Nat Biomed Eng. 2023 Nov 23. doi: 10.1038/s41551-023-01140-z. PubMed |
| Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage. Shukla N, Roelle SM, Snell JC, DelSignore O, Bruchez AM, Matreyek KA. bioRxiv [Preprint]. 2024 Feb 14:2024.02.13.580056. doi: 10.1101/2024.02.13.580056. PubMed |
| High-Content Imaging-Based Assay for SARS-CoV-2-Neutralizing Antibodies. Rocha VPC, Machado BAS, Quadros HC, Fernandes AMS, Fiuza BSD, Meira CS, da Silva VTB, Evangelista AF, Fonseca LMDS, Badaro RJDS, Soares MBP. Vaccines (Basel). 2024 Feb 24;12(3):236. doi: 10.3390/vaccines12030236. PubMed |
| Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. PubMed |
| SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells. Antia A, Alvarado DM, Zeng Q, Casorla-Perez LA, Davis DL, Sonnek NM, Ciorba MA, Ding S. Viruses. 2024 Apr 19;16(4):634. doi: 10.3390/v16040634. PubMed |
Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage.
Shukla N, Roelle SM, Snell JC, DelSignore O, Bruchez AM, Matreyek KA.
PLoS Pathog. 2024 May 20;20(5):e1012044. doi: 10.1371/journal.ppat.1012044.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.